Yusuke Kanemasa

15PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 22, 2026
Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

|Jan 27, 2026
Concurrent tumor lysis syndrome and 5-fluorouracil encephalopathy during the first cycle of zolbetuximab plus mFOLFOX6 for CLDN18.2-positive gastric cancer: a case report.

Taichi Tamura, Yusuke Kanemasa, Yusuke Masuda

|Sep 12, 2025
Genetic prognostic markers in LymphGen-unclassifiable diffuse large B cell lymphoma.

Yusuke Kanemasa, Daichi Sadato, Maya Isogai

|May 27, 2025
Site- and Stage-Adapted Treatment Strategies for Gastrointestinal Diffuse Large B-Cell Lymphoma.

Yu Yagi, Yusuke Kanemasa, Yuki Sasaki

|Oct 14, 2024
Management of HER2-positive and microsatellite instability-high advanced gastric cancer: a case report.

Taichi Tamura, Yusuke Kanemasa, Shohei Nakamura

|Aug 28, 2023
Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy: A retrospective study.

Yu Yagi, Yusuke Kanemasa, Yuki Sasaki

Pageof 3

Frequent Collaborators

1 joint publications

Tatsuya Konishi

1 joint publications

Yuho Najima

1 joint publications

Toshiki Terao

1 joint publications

Ryo Hanajiri